TrialNeuro-oncology2019
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.
Denis Migliorini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
85 papers cite itlatest 60 shown
this paperpooled ittrialcites it